SURVEY OF INSTITUTIONAL HANDLING OF REGENERATIVE MEDICAL PRODUCTS CONDUCTED BY THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY IN 2022

Author:

Kobayashi Hirohito12,Yakushijin Kimikazu3,Anan Masahiro4,Ikeda Kazuhiko5,Okuyama Yoshiki6,Fujiwara Shin-ichiro7,Kanno Hitoshi2,Tanosaki Ryuji8,Nakayama Takayuki9,Nagamura-Inoue Tokiko10

Affiliation:

1. Division of Transfusion and Cell Therapy, Tokyo Women's Medical University, Adachi Medical Center

2. Department of Transfusion and Cell Processing, Tokyo Women's Medical University Hospital

3. Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine

4. Department of Transfusion Medicine, Saitama Medical Center, Saitama Medical University

5. Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine

6. Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

7. Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital

8. Center for Transfusion Medicine and Cell Therapy, Keio University School of Medicine

9. Clinical Laboratory, Aichi Medical University

10. Department of Cell Processing and Transfusion, Research Hospital, The Institute of Medical Science, The University of Tokyo

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3